Patents by Inventor Brian R. BETTENCOURT

Brian R. BETTENCOURT has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230313185
    Abstract: The present disclosure features useful compositions and methods to treat repeat expansion disorders (e.g., trinucleotide repeat expansion disorders), in a subject in need thereof. In some aspects, the compositions and methods described herein are useful in the treatment of disorders associated with MSH3 activity.
    Type: Application
    Filed: May 7, 2021
    Publication date: October 5, 2023
    Inventors: Nessan Anthony BERMINGHAM, Brian R. BETTENCOURT, Peter Edward BIALEK
  • Publication number: 20230068672
    Abstract: The present disclosure features useful compositions and methods to treat nucleotide repeat expansion disorders, e.g., in a subject in need thereof. In some aspects, the compositions and methods described herein are useful in the treatment of disorders associated with MSH3 activity.
    Type: Application
    Filed: June 16, 2022
    Publication date: March 2, 2023
    Inventors: Nessan Anthony Bermingham, Brian R. Bettencourt, Pei Ge
  • Publication number: 20230041178
    Abstract: The present disclosure features useful compositions and methods to treat trinucleotide repeat expansion disorders, e.g., in a subject in need thereof. In some aspects, the compositions and methods described herein are useful in the treatment of disorders associated with OGG1 activity.
    Type: Application
    Filed: December 2, 2019
    Publication date: February 9, 2023
    Applicant: Triplet Therapeutics, Inc.
    Inventors: Nessan Anthony BERMINGHAM, Brian R. BETTENCOURT, Peter Edward BIALEK
  • Publication number: 20230042436
    Abstract: The present disclosure features useful compositions and methods to treat repeat expansion disorders, e.g., in a subject in need thereof. In some aspects, the compositions and methods described herein are useful in the treatment of disorders associated with MLH3 activity.
    Type: Application
    Filed: December 2, 2019
    Publication date: February 9, 2023
    Inventors: Nessan Anthony BERMINGHAM, Brian R. BETTENCOURT, Peter Edward BIALEK
  • Patent number: 11408000
    Abstract: The present disclosure features useful compositions and methods to treat nucleotide repeat expansion disorders, e.g., in a subject in need thereof. In some aspects, the compositions and methods described herein are useful in the treatment of disorders associated with MSH3 activity.
    Type: Grant
    Filed: June 2, 2021
    Date of Patent: August 9, 2022
    Assignee: Triplet Therapeutics, Inc.
    Inventors: Nessan Anthony Bermingham, Brian R. Bettencourt, Pei Ge
  • Publication number: 20220072028
    Abstract: The present disclosure features useful compositions and methods to treat trinucleotide repeat expansion disorders, e.g., in a subject in need thereof. In some aspects, the compositions and methods described herein are useful in the treatment of disorders associated with MSH3 activity.
    Type: Application
    Filed: December 2, 2019
    Publication date: March 10, 2022
    Inventors: Nessan Anthony BERMINGHAM, Brian R. BETTENCOURT, Peter Edward BIALEK
  • Publication number: 20220033814
    Abstract: The present disclosure features useful compositions and methods to treat repeat expansion disorders, e.g., in a subject in need thereof. In some aspects, the compositions and methods described herein are useful in the treatment of disorders associated with MLH1 activity.
    Type: Application
    Filed: December 2, 2019
    Publication date: February 3, 2022
    Inventors: Nessan Anthony BERMINGHAM, Brian R. BETTENCOURT, Peter Edward BIALEK
  • Publication number: 20210395740
    Abstract: The present disclosure features useful compositions and methods to treat nucleotide repeat expansion disorders, e.g., in a subject in need thereof. In some aspects, the compositions and methods described herein are useful in the treatment of disorders associated with MSH3 activity.
    Type: Application
    Filed: June 2, 2021
    Publication date: December 23, 2021
    Inventors: Nessan Anthony BERMINGHAM, Brian R. BETTENCOURT, Pei GE